Development of a Biological Database in the Field of Operative Intensive Care
ConditionIntensive Care in General
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRWTH Aachen University
About this trial
The storage and use of biomaterial samples is an important requirement for accompanying research and the acquisition of new knowledge to improve prognosis and therapy. Biobanking is explicitly recommended in official guidelines. In order to preserve the biomaterial, the patient must consent to the removal, transfer and storage of the biomaterial separately from the consent to the register. The biomaterial is taken at times at which a blood or urine sampling takes place anyway in the clinical routine. Therefore no additional interventions are necessary.
Eligibility criteria
Qualifiers
patients after admission to the intensive care unit
18 years or older
signed informed consent
Disqualifiers
No exclusion criteria are formulated with regard to the objective of the register to record intensive care patients in general. Patients with multiple comorbidities, organ dysfunctions, and non-compliance for a curatively-intended therapy should also be recorded in the register. A palliative treatment or decision for best supportive care is not an exclusion criterion for registering.
Trial design
Treatments tested in this trial
- Biological Database
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov